Monday, 09 December 2019

Drug Discovery News

  • UCLA finds new compound to curb Alzheimer's

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: Researchers at University of California, Los Angeles (UCLA), US, have reported the development of a molecular compound, CLR01, which has been found to prevent toxic proteins from...Read more

  • Dainippon, Nippon Shinyaku sign deal for new drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have concluded a license agreement for exclusive rights to develop, manufac...Read more

  • AVEO, Astellas file NDA for tivozanib

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

    Singapore: US-based AVEO Oncology and Astellas Pharma have submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tivozanib in patients wit...Read more

  • Sanofi seeks approval for Lyxumia in Japan

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational once-daily GLP-1 receptor agonist, to the Ministry of Health, Labour ...Read more

  • Cadila, Swedish firm develop arthritis drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jan, 2014

    Singapore: NovaSAID, part of Sweden-based Karolinska Development, and India- based Cadila Pharmaceuticals have entered into a strategic partnership to develop new treatments for inflammatio...Read more

  • Diabetes drug Actos doubles risk of bladder cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

    Singapore: Canadian scientists have revealed that the diabetes drug pioglitazone, also known as Actos, doubles the risk of bladder cancer. However, the researchers found that in absolute te...Read more

  • Taiwan, China firms to co-develop cancer NCEs

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

    Singapore: Taiwan's PharmaEngine has collaborated and signed research agreement with China's Guangzhou BeBetter Medicine Technology. The two companies will collaborate to design, synthesize...Read more

  • Eisai to launch breast cancer drug in India

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel anti-cancer drug Eribulin, sold under the brand name of Halaven in Ind...Read more

  • Prana Biotech readies to progress PBT2 to market

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Australia-based Prana Biotechnology is to make senior appointments as it prepares to advance its key drug to treat Alzheimer's and Huntington diseases into late stage and pre-mar...Read more

  • Oramed recruits patients for oral insulin trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Oramed Pharmaceuticals initiated patient recruitment for a new clinical trial of its orally ingestible insulin capsule,ORMD-0801, for patients with type 1 diabetes mellitus (T1DM...Read more

  • GlobalData: New Zealand focuses on generics

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

    Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emphasising on generics, despite the disproportionate growth in elderly ...Read more

  • Allied to soon get CE mark approval from EU

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approval for CardioCel, its lead regenerative tissue product for the repair ...Read more

  • Rockefeller University finds genetic link to autism

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

    Singapore: A collaborative research effort at Duke University Medical Center and Rockefeller University has pinpointed the precise genetic footprint that links fragile X syndrome and autism...Read more

  • GSK, Theravance COPD drug gets FDA nod

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Apr, 2013

    Singapore: The US FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has approved GlaxoSmithKline (GSK) and Theravance's Breo Ellipta as a once-daily inhaled treatment for the long-te...Read more

  • Bayer gets Japan's nod for gastro tumor drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastrointestinal stromal tumor (GIST) who have progressed following prior ...Read more

  • Theravance, Alfa Wassermann collaborate

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in certain countries for velusetrag, Theravance's investigational 5-HT4 agon...Read more

  • Epilepsy Foundation asks DEA to better review process

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Epilepsy Foundation of US has called on the Drug Enforcement Administration (DEA), US, to revise its process for reviewing new treatments, which currently lack innovation and tra...Read more

  • Fight against TB needs $1.6 bn funding annually

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2013

    Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at l...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls